Previous Article | Next Article ![]()
Journal of Clinical Microbiology, January 2001, p. 266-269, Vol. 39, No. 1
Departments of Infectious
Diseases1 and
Pathology,2 Stanford University Medical
Center, Stanford, California 94305-5250
Received 28 June 2000/Returned for modification 4 September
2000/Accepted 17 October 2000
The methylene blue stain for fecal leukocytes (FL) is widely used
as an adjunct to slower but more accurate tests of diarrheal etiology,
such as stool culture (SCx) or toxin assays for Clostridium difficile. Prior studies investigating the utility of FL for
predicting SCx and C. difficile toxin assay (CDTA) results
did not evaluate the importance of inpatient versus outpatient status.
We conducted a study of patients who submitted a stool specimen to the
Stanford Hospital Microbiology Laboratory between May 1998 and April
1999. The results for stool specimens that were tested by FL and by a
confirmatory test (either SCx or CDTA) were used to determine whether
the FL method helped to predict the results of these tests. Of 797 stools that were tested by FL method and at least one confirmatory test, 502 stools were tested by CDTA, and 473 stools were cultured. The
FL test was 14% sensitive and 90% specific for C. difficile with a diagnostic threshold of one white blood
cell/high-power field (WBC/HPF). The overall likelihood ratio (LR) for
a positive CDTA was 1.4 with a 95% confidence interval (CI) of 0.5 to
3.7 (P = 0.5) and was similar among inpatients and
outpatients. In contrast, the presence of
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.1.266-269.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Fecal Leukocyte Stain Has Diagnostic Value for
Outpatients but Not Inpatients
1 WBC/HPF was 52%
sensitive and 88% specific for the 27 positive SCx results and helped
to predict a positive SCx result (LR, 4.2; 95% CI, 2.7 to 6.5;
P < 0.001). The sensitivity of
1 WBC/HPF was 57%,
and its predictive value for SCx was higher among outpatients
(outpatient LR, 5.0; 95% CI, 2.9 to 8.6; P < 0.001;
inpatient LR, 1.9; 95% CI, 0.3 to 10.8; P = 0.5).
Among inpatients, only 4 (1.5%) of the 273 SCx results were positive,
and the presence of
1 WBC/HPF was insensitive (25%) and did not
predict a positive SCx (LR, 1.9; 95% CI, 0.3 to 10.8;
P = 0.5). When the data were reanalyzed using a
diagnostic threshold of five WBC/HPF for FL, the predictive power of
the FL method was similar. Thus, FL was of no value in predicting CDTA
positivity, nor was it helpful in predicting SCx results for
inpatients. Neither SCx nor the FL method should routinely be performed
on samples from inpatients. Among outpatients, presence of FLs should
suggest a bacterial diarrhea in clinically compatible cases.
*
Corresponding author. Mailing address: Clinical
Microbiology/Virology Laboratory, Stanford University Hospital, Rm.
H1537-J, MC 5629, 300 Pasteur Dr., Stanford, CA 94305-5250. Phone:
(650) 725-3773. Fax: (650) 725-5671. E-mail:
ejbaron{at}stanford.edu.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»